What is the appropriate workup for anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Anemia

Begin the anemia workup with a complete blood count (CBC) with red cell indices, reticulocyte count, iron studies (serum ferritin and transferrin saturation), and inflammatory markers (C-reactive protein), which together provide the essential foundation for diagnosing the vast majority of anemias. 1, 2, 3

Define Anemia and Initiate Workup

Diagnostic thresholds:

  • Hemoglobin < 13 g/dL in men 1, 2, 3
  • Hemoglobin < 12 g/dL in non-pregnant women 1, 2, 3
  • Hemoglobin < 11 g/dL in pregnant women 1, 2

For chronic kidney disease patients specifically, initiate workup when: 4

  • Hemoglobin < 12 g/dL (Hct < 37%) in adult males and post-menopausal females 4
  • Hemoglobin < 11 g/dL (Hct < 33%) in pre-menopausal females and pre-pubertal patients 4

Essential First-Line Laboratory Tests

Order these tests simultaneously at initial presentation: 1, 2, 3

  1. Complete blood count with red cell indices - provides hemoglobin, hematocrit, MCV, MCH, MCHC, and RDW 1, 2, 3
  2. Reticulocyte count - distinguishes impaired production (low/normal) from increased destruction or blood loss (elevated) 1, 2, 3
  3. Iron studies panel: 1, 2, 3
    • Serum ferritin (< 30 μg/L confirms iron deficiency without inflammation) 1, 2
    • Transferrin saturation (< 15-16% supports iron deficiency) 1, 2
    • Total iron-binding capacity 3
  4. C-reactive protein - identifies inflammatory states that affect ferritin interpretation 1, 3

Critical technical point: Use automated cell counters for all measurements, and in hemodialysis patients, obtain samples pre-dialysis as post-dialysis values are unreliable due to hemoconcentration 4

Algorithmic Classification by MCV

Microcytic Anemia (MCV < 80 fL)

Most common causes: 1, 2, 3

  • Iron deficiency anemia (most common)
  • Thalassemia trait
  • Anemia of chronic disease
  • Sideroblastic anemia

Diagnostic approach:

  • If ferritin < 30 μg/L and transferrin saturation < 15%, diagnose iron deficiency anemia 1, 2
  • If iron studies are normal, obtain hemoglobin electrophoresis to evaluate for thalassemia, particularly in patients of Mediterranean, African, or Southeast Asian descent 1
  • MCH is more reliable than MCHC for detecting iron deficiency as it's less dependent on storage conditions 1

Normocytic Anemia (MCV 80-100 fL)

Most common causes: 2, 3

  • Acute blood loss
  • Hemolysis
  • Anemia of chronic disease/inflammation
  • Early iron deficiency
  • Chronic kidney disease

Diagnostic approach:

  • Elevated RDW with normal MCV suggests early iron deficiency or mixed nutritional deficiencies 1
  • Low MCHC with normal MCV indicates hypochromia, often accompanying iron deficiency 1
  • If hemolysis suspected, measure haptoglobin, LDH, and bilirubin 1
  • Assess for chronic diseases and inflammatory conditions 1, 3

Macrocytic Anemia (MCV > 100 fL)

Most common causes: 1, 2, 3

  • Vitamin B12 deficiency
  • Folate deficiency
  • Medications (methotrexate, hydroxyurea, antiretrovirals)
  • Alcohol use
  • Myelodysplastic syndrome

Diagnostic approach:

  • Measure vitamin B12 and folate levels 1, 2
  • Review medication list for causative agents 3
  • Consider bone marrow evaluation if other causes excluded 3

Special Population Considerations

Chronic Kidney Disease Patients

Monitoring frequency: 2, 3

  • Check hemoglobin at least every 3 months in patients with GFR < 30 mL/min/1.73 m² 2, 3
  • Initiate full workup if hemoglobin drops below thresholds listed above 2, 3

Treatment sequence: 2

  • Treat identified iron deficiency first 2
  • If anemia persists despite iron repletion, consider erythropoietin therapy 2
  • Do NOT routinely measure serum erythropoietin levels in CKD patients with normochromic, normocytic anemia—it's not clinically useful 2

High-Risk Patients Requiring Regular Monitoring

Screen regularly in: 1

  • Chronic kidney disease patients 1
  • Inflammatory bowel disease patients 1
  • Other chronic inflammatory conditions 1

Critical Pitfalls to Avoid

Never assume anemia is "normal aging" in elderly patients—always investigate the underlying cause, as this represents a dangerous and common error. 2, 3

Watch for combined deficiencies: 2, 3

  • Elderly patients and those with inflammatory bowel disease frequently have multiple concurrent deficiencies (e.g., iron plus B12) 2, 3
  • Treating only one deficiency will result in persistent anemia 2, 3

Ferritin interpretation requires clinical context: 1

  • Ferritin is an acute phase reactant and can be falsely elevated in inflammation, chronic disease, malignancy, or liver disease 1
  • In inflammatory states, ferritin < 100 μg/L may still indicate iron deficiency 1

High-dose folic acid supplementation can mask B12 deficiency symptoms while allowing neurologic damage to progress—always check B12 before treating with folate. 1

In adults with confirmed iron deficiency, investigate for blood loss: 1

  • Gastrointestinal evaluation is warranted in adult men and postmenopausal women without obvious bleeding source 1
  • Menstrual losses explain most cases in premenopausal women 1

When to Consider Bone Marrow Examination

Reserve bone marrow evaluation for: 3

  • Unexplained normocytic or macrocytic anemia after initial workup 3
  • Suspected myelodysplastic syndrome 3
  • Pancytopenia or other cytopenias 3
  • Atypical presentations not explained by standard testing 3

References

Guideline

Anemia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Anemia Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach and Management of Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.